University study seeks feedback on a new decision making resource for bipolar disorder

17 February 2017

Alana Fisher, a PhD student, is conducting a new study around decision making in treatment of bipolar 2 disorder. This study will be under the supervision of Dr Ilona Juraskova and Prof Louise Sharpe at the University of Sydney and Dr Josephine Anderson and A/Prof Vijaya Manicavasagar at the Black Dog Institute. 

Many people with bipolar II disorder and their family want to be more informed and more involved in decision-making about their treatment.

To this end, researchers are looking to evaluate the usefulness of a new decision-making resource designed to help people with bipolar II and their family to make the “right” treatment decision for them. That is, a treatment decision that takes into account the best available clinical evidence as well as what is important to and matters most to their people in their treatment based on their values and life situation. 

Who does this study involve?

  • People with bipolar II disorder (18-65 years) who have had or are having to make a decision about treatment to maintain wellness/prevent relapse.
  • The family member of someone with bipolar II disorder (18-65 years) who has helped or is helping to make a decision about their treatment to maintain wellness/prevent relapse.

What does the study involve?

The study involves reading through a booklet, completing a questionnaire as well as a one-off phone interview (about 20-30 minutes), to get your feedback on whether the decision-making resource is useful, and covers all information in the best way possible.

Why is this study needed?

This research will help future patients and their family members to make better decisions within consultations about treatment and management of bipolar II disorder.

Are you interested?

Please email details of your name, best contact phone and email to or call 9036 9258. A researcher from the University of Sydney will then contact you about the study.


Thank you for your consideration of this study.

Please Note: This study has been approved by Human Review Ethics Committee at the University of Sydney 2016/763.